Close
Digital Health & Ai Innovation summit 2026
APE 2026

Ziehm Imaging receives 2009 Business Development Strategy Leadership Award from Frost & Sullivan

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Natera Adds ctDNA-Based MRD Tests with...

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from...

The federal government has formally withdrawn the Biden-era minimum...

The German medical device company Ziehm Imaging has received the “2009 European Mobile C-arms Business Development Strategy Leadership Award” from the independent market research company Frost & Sullivan. The award recognizes the successful growth strategy of the technology leader in the area of mobile C-arms. Selection criteria were above all the opening up of important new markets, as well as the securing of strategic partnerships.

The award recognizes the firm’s unique strategic developments and technical supremacy in the area of mobile C-arms in Europe. During the last three years, through close co-operations with clinics and partnerships with other med-tech companies, Ziehm Imaging has been consistently able to develop its x-ray-based imaging technology and achieve technological leadership. The forward-looking development of the flat-panel technology contributed to the company winning the 2006 Frost & Sullivan Award for Innovation and the 2007 Frost & Sullivan Award for Technology Leadership. With more than 100 installations of this technology, the company today remains the undisputed market leader.

Latest stories

Related stories

Natera Adds ctDNA-Based MRD Tests with Acquisition of Foresight Diagnostics

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from Minimum Nurse Staffing Rule Repeal

The federal government has formally withdrawn the Biden-era minimum...

Purehealth, Dorchester Partner to Bring Luxury Hospitality in Healthcare

PureHealth has gone on to announce a first-of-its-kind partnership...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »